AIM ImmunoTech (0A4Y) Income Statement
AIM ImmunoTech Income Statement
Last quarter (Q2 2026), AIM ImmunoTech's total revenue was $26.00K, an increase of 4.00% from the same quarter last year. In Q2, AIM ImmunoTech's net income was $-3.79M. See AIM ImmunoTech’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Dec 24 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 88.00K | $ 170.00K | $ 202.00K | $ 141.00K | $ 135.00K | |
| $ -250.00K | $ 139.00K | $ 160.00K | $ 141.00K | $ -715.00K | |
| $ 10.28M | $ 19.91M | $ 32.08M | $ 20.06M | $ 18.12M | |
| Depreciation and Amortization | $ 210.00K | $ 246.00K | $ 238.00K | $ 256.00K | $ 775.00K |
| $ -12.94M | $ -16.49M | $ -28.72M | $ -19.19M | $ -18.29M | |
| $ -10.53M | $ -19.77M | $ -31.92M | $ -19.92M | $ -18.84M | |
| $ -3.43M | $ 2.45M | $ 2.95M | $ 477.81K | $ -289.00K | |
| $ -13.96M | $ -17.32M | $ -28.96M | $ -19.45M | $ -19.13M | |
| $ -13.96M | $ -17.32M | $ -28.96M | $ -19.45M | $ -19.13M | |
| Per Share Metrics | |||||
| Basic EPS | $ -8.62 | $ -11.22 | $ -21.64 | $ -14.69 | $ -14.67 |
| Diluted EPS | $ -8.62 | $ -11.22 | $ -21.64 | $ -14.69 | $ -14.67 |
| Weighted Average Shares Outstanding | 1.62M | 1.54M | 1.34M | 1.32M | 1.30M |
| Weighted Average Shares Outstanding (Diluted) | 1.62M | 1.54M | 1.34M | 1.32M | 1.30M |
Currency in USD
